Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation.

MLA

Franchetti, Yoko, and Thomas D. Nolin. “Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation.” Journal of Clinical Pharmacology, vol. 60 Suppl 1, Oct. 2020, pp. S36–51. EBSCOhost, https://doi.org/10.1002/jcph.1741.

APA

Franchetti, Y., & Nolin, T. D. (2020). Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation. Journal of Clinical Pharmacology, 60 Suppl 1, S36–S51. https://doi.org/10.1002/jcph.1741

Chicago

Franchetti, Yoko, and Thomas D Nolin. 2020. “Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation.” Journal of Clinical Pharmacology 60 Suppl 1 (October): S36–51. doi:10.1002/jcph.1741.